Invesco Ltd.

IVZ 10-Q · Q3 2025

IVZ Q3 2025 request

Playground key active
Request URL /api/financials?ticker=IVZ&year=2025&quarter=3
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q3 2025 Q3 2024 YoY
Revenue 1,640.4 1,515.4 +8.2%
Show Product Lines breakouts
Distribution And Shareholder Service 400.7 360.3 +11.2%
Financial Service Other 48.5 51.8 -6.4%
Investment Advice 1,184.7 1,100.5 +7.7%
Investment Performance 6.5 2.8 +132.1%
Show Geography breakouts
Americas 1,213.4 1,158.9 +4.7%
Asia Pacific 76.8 66 +16.4%
EMEA 350.2 290.5 +20.6%
Third Party Distribution Service And Advisory 558.3 499.6 +11.7%
Labor And Related Expense 521.6 625.4 -16.6%
Marketing Expense 20.1 18.9 +6.3%
Communications Information Technology And Occupancy 109.2 119 -8.2%
General & Administrative 151.3 140.8 +7.5%
Amortization Of Intangible Assets 9 11.2 -19.6%
Operating Expenses 1,369.5 1,414.9 -3.2%
Operating Income 270.9 100.5 +169.6%
Income Loss From Equity Method Investments 34.8 2.1 +1557.1%
Investment Income Interest And Dividend 10.5 10.9 -3.7%
Interest Expense -25.7 -13.4 -91.8%
Other Non-Operating Income (Expense) -0.8 28.3 -102.8%
Other Nonoperating Income Expense Consolidated Investment Products 57 16.7 +241.3%
Income Before Taxes 346.7 145.1 +138.9%
Income Tax Expense (Benefit) 9.7 -41.5 +123.4%
Net Income 356.4 103.6 +244.0%
Net Income Loss Attributable To Noncontrolling Interest -10.7 10.6 -200.9%
Preferred Stock Dividends And Other Adjustments -44.4 -59.2 +25.0%
Net Income Loss Available To Common Stockholders Basic 301.3 55 +447.8%
EPS (Basic) 0.67 0.12 +458.3%
EPS (Diluted) 0.66 0.12 +450.0%
Comprehensive Income 229.8 240.3 -4.4%
Wtd Avg Shares (Basic) 452.4 454.9 -0.5%
Wtd Avg Shares (Diluted) 454.6 455.6 -0.2%

Balance Sheet

Balance Sheet
Metric Q3 2025 Q3 2024 YoY
Current Assets
Cash & Cash Equivalents 973.1 1,044.9 -6.9%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 550.7
Show Fair Value By Measurement Basis breakouts
Estimate Of Fair Value Fair Value Disclosure 973.1
Short-Term Investments (Q)
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Investments related to deferred compensation plans 125.5
Fair Value Inputs Level1 · Seed capital 203.4
Show Fair Value By Asset Class breakouts
Investments related to deferred compensation plans 125.5
Seed capital 203.4
Show Fair Value By Measurement Basis breakouts
Estimate Of Fair Value Fair Value Disclosure 328.9
Non-Current Assets
Property, Plant & Equipment 387.7 580.3 -33.2%
Goodwill 8,459.8 8,730.4 -3.1%
Total Assets 28,438.9
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 9,556.2
Other Assets
Accounts Receivable Net 810.5 710.8 +14.0%
Investments 1,164.2
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 8,663.3
Other Assets 1,356.2 884 +53.4%
Intangible Assets Net Excluding Goodwill 5,731.2 5,816.7 -1.5%
Investments And Other Assets Of Variable Interest Entities 9,556.2
Non-Current Liabilities
Employee Related Liabilities Current And Noncurrent 893 886.5 +0.7%
Accounts Payable And Accrued Liabilities Current And Noncurrent 1,496.2 1,455.6 +2.8%
Long-Term Debt 1,624.6
Show Debt Instrument breakouts
$400 million 5.375% - due November 30, 2043 · Carrying Reported Amount Fair Value Disclosure 391.5
$400 million 5.375% - due November 30, 2043 · Estimate Of Fair Value Fair Value Disclosure 382.7
$500 million - due May 16, 2028 (3) · Carrying Reported Amount Fair Value Disclosure 237.7
$500 million - due May 16, 2028 (3) · Estimate Of Fair Value Fair Value Disclosure 238.7
$500 million - due May 16, 2030 · Carrying Reported Amount Fair Value Disclosure 495.6
$500 million - due May 16, 2030 · Estimate Of Fair Value Fair Value Disclosure 496.6
$500 million 3.750% - due January 15, 2026 · Carrying Reported Amount Fair Value Disclosure 499.8
$500 million 3.750% - due January 15, 2026 · Estimate Of Fair Value Fair Value Disclosure 498.5
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 6,734.7
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 1,624.6
Estimate Of Fair Value Fair Value Disclosure 1,616.5
Deferred Tax Liabilities 1,318.8 1,316.9 +0.1%
Total Liabilities 13,646.6
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 8,314
Other Liabilities
Long Term Debt Of Consolidated Investment Products 8,314 6,562.6 +26.7%
Stockholders' Equity
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests 150.5 580.5 -74.1%
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 150.5
Preferred Stock Value 3,010.5 4,010.5 -24.9%
Common Stock 113.2 113.2 0.0%
Additional Paid In Capital Common Stock 7,253.9 7,325.2 -1.0%
Treasury Stock Value -2,803.9 -2,832 +1.0%
Retained Earnings 7,167.6 6,874 +4.3%
Accumulated Other Comprehensive Income -735.7 -736.6 +0.1%
Total Stockholders' Equity 14,005.6 14,754.3 -5.1%
Minority Interest 636.2 571.8 +11.3%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 14,641.8 15,326.1 -4.5%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -128.8 -129.1 +0.2%
Accumulated Other Comprehensive Income -735.7 -736.6 +0.1%
Accumulated Translation Adjustment -606.9 -607.5 +0.1%
Additional Paid In Capital 7,253.9 7,325.2 -1.0%
Common Stock 113.2 113.2 0.0%
Noncontrolling Interest 636.2 571.8 +11.3%
Parent 14,005.6 14,754.3 -5.1%
Preferred Stock 3,010.5 4,010.5 -24.9%
Retained Earnings 7,167.6 6,874 +4.3%
Treasury Stock Common -2,803.9 -2,832 +1.0%
Total Liabilities & Equity 28,438.9
Show Consolidated Entities breakouts
Variable Interest Entity Primary Beneficiary 9,556.2

Cash Flow Statement

Cash Flow Statement
Metric YTD Q3 2025 YTD Q3 2024 YoY
Operating Activities
Depreciation & Amortization 119.9 135.5 -11.5%
Stock-Based Compensation 59.8 90.5 -33.9%
Other Non-Cash Items -31.6 -67.2 +53.0%
Gains And Losses Of Consolidated Investment Products Net -27.7 22.2 -224.8%
Equity Method Investment Dividends Or Distributions 40.7 83.1 -51.0%
Purchasesaleofinvestmentsby C I Pnet 57 17.2 +231.4%
Payments For Proceeds From Short Term Investments 81.5 -80.3 +201.5%
Increase Decrease In Accounts Receivable And Other Operating Assets -123.2 365.3 -133.7%
Increase Decrease In Accounts Payable And Other Operating Liabilities 151.4 -184 +182.3%
Net Cash from Operations 1,069.5 873.1 +22.5%
Investing Activities
Capital Expenditures -60.7 -76.1 +20.2%
Purchase Of Investments By Consolidated Investment Products -3,059.9 -3,089.6 +1.0%
Proceeds From Sale Of Investments By Consolidated Investment Products 2,470.3 3,310.1 -25.4%
Payments To Acquire Other Investments -30 -140.3 +78.6%
Proceeds From Sale Of Other Investments 0.1 0.2 -50.0%
Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 59.7 122.1 -51.1%
Proceeds From Payments To Consolidation And Deconsolidation Of Subsidiaries -1.7 -41.1 +95.9%
Net Cash from Investing -622.2 85.3 -829.4%
Financing Activities
Share Repurchases -97.8 -53.3 -83.5%
Payments For Repurchase Of Preferred Stock And Preference Stock -1,150
Payments Of Dividends Preferred Stock And Preference Stock -160.2 -177.6 +9.8%
Payments Of Dividends Common Stock -282.7 -278.7 -1.4%
Capital Invested Into Consolidated Investment Products 176.9 125.5 +41.0%
Capital Distributed By Consolidated Investment Products -157.2 -159.8 +1.6%
Proceedsfrom Debt Consolidated Investment Products 2,970.7 351.2 +745.9%
Repayments Of Consolidated Investment Products -2,538 -476.4 -432.7%
Proceeds From Lines Of Credit 2,072.7 1,920.3 +7.9%
Repayments Of Lines Of Credit -2,072.7 -1,920.3 -7.9%
Proceeds From Issuance Of Long Term Debt 992.7
Repayments Of Bank Debt -260 -600 +56.7%
Repayments Of Bank Debt (Q)
Show Debt Instrument breakouts
$500 million - due May 16, 2028 (3) · Bank Term Loans -260
Net Cash from Financing -505.6 -1,269.1 +60.2%
Supplemental
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 49.7 16.8 +195.8%
Effectof Exchange Rateon Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents C I P 36.4 1.7 +2041.2%
Other Cash Flow
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -58.3 -310.7 +81.2%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,523.8 1,639.4 -7.1%
Cash And Cash Equivalents Of Consolidated Investment Products 550.7 594.5 -7.4%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key